Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Asset Writedowns and Impairment (2021 - 2024)

Trulieve Cannabis (TCNNF) has 4 years of Asset Writedowns and Impairment data on record, last reported at -$8.9 million in Q3 2024.

  • For Q3 2024, Asset Writedowns and Impairment fell 52.09% year-over-year to -$8.9 million; the TTM value through Sep 2024 reached -$2.5 million, up 96.46%, while the annual FY2023 figure was $2.8 million, 23.97% down from the prior year.
  • Asset Writedowns and Impairment reached -$8.9 million in Q3 2024 per TCNNF's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $54.6 million in Q3 2022 and bottomed at -$72.5 million in Q4 2022.
  • Average Asset Writedowns and Impairment over 4 years is $161583.3, with a median of $757500.0 recorded in 2022.
  • Peak YoY movement for Asset Writedowns and Impairment: skyrocketed 1092880.0% in 2022, then crashed 478.57% in 2023.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at -$5000.0 in 2021, then crashed by 1450660.0% to -$72.5 million in 2022, then surged by 102.6% to $1.9 million in 2023, then plummeted by 570.06% to -$8.9 million in 2024.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were -$8.9 million in Q3 2024, $1.5 million in Q2 2024, and $3.0 million in Q1 2024.